A prospective study of blood alpha-fetoprotein messenger RNa as a predictor of hepatocellular carcinoma in patients with cirrhosis

Journal of Viral Hepatitis

Volumn 10, Issue 6, 2003, Pages 423-426

  Iavarone, M ^a   Lampertico, P ^a   Ronchi, G ^a   Del Ninno, E ^a   Zanella, A ^b   Colombo, M ^a,c  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Alpha fetoprotein; Circulating tumour cells; Cirrhosis; Hepatocellular carcinoma; Reverse transcriptase polymerase chain reaction

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ACCURACY; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; DISEASE MARKER; ECHOGRAPHY; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0242361686     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00459.x     Document Type: Article

References (19)

1. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona EASL Conference. J Hepatol 2001; 35: 421-430.
2. Ebara M, Ohto M, Kondo F. Strategy for early diagnosis of hepatocellular carcinoma (HCC). Ann Acad Med Singapore 1989; 18: 83-89.
3. Wakasa K, Sakurai M, Okamura J, Kuroda C. Pathological study of small hepatocellular carcinoma: frequency of their invasion. Virchows Arch A Pathol Anat Histopathol 1985; 407(3): 259-270.
4. Tsai TJ, Chau GY, Lui WY et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127: 603-608.
5. Matsumura M, Niwa Y, Kato N et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20: 1418-1425.
6. Louha M, Poussin K, Ganne N et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997; 26: 998-1005.
7. Komeda T, Fukuda Y, Sando T et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75: 2214-2219.
8. Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997; 25: 564-568.
9. Matsumura M, Shiratori Y, Tanaka T et al. Presence of alpha-fetoprotein in blood correlates with outcome in patients with hepatocellular carcinoma. J Hepatol 1999; 31: 332-339.
10. Luo W, Yatsuhashi H, Hamada R et al. Analysis of alpha-fetoprotein mRNA in peripheral blood: detection and semi-quantitation by reverse transcription polymerase chain reaction. Hepatol Res 1999; 14: 1-12.
11. Okuda N, Nakao A, Takeda S et al. Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC. Hepato-gastroenterol 1999; 46: 381-386.
12. Louha M, Nicolet J, Zylberberg H et al. Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology 1999; 29: 879-882.
13. Lemoine A, Le Bricon T, Salvucci M et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 1997; 226: 43-50.
14. Kedda MA, Kew M, Skelton M, Hodkinson J. Non-specificity of messenger RNA of alpha-fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans. J Gastroenterol Hepatol 1998; 13: 885-891.
15. Wong IHN, Lay WY, Leung T, Johnson PJ. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000; 156: 141-149.
16. Niwa Y, Matsumura M, Shiratori Y et al. Quantitation of alpha-fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma. Hepatology 1996; 23: 1384-1392.
17. Kakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985; 82: 6133-6137.
18. Hermanek P, Hutter RPV, Sobin LH, Wittekind C. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668-2673.
19. Kawai HF, Kaneko S, Honda M, Shirota Y, Kobayashi K. α-Fetoprotein- producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Hepatology 2001; 33: 676-691.